Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

David Pérol

7PUBLICATIONS
46CO-AUTHORS
Cross-sectional analysisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Sep 10, 2025
Reply to: Critical evaluation of the ProfiLER-02 study design and outcomes.

Olivier Trédan, Marie-Sarah Cabrillac, Sylvie Chabaud

|Apr 08, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Olivier Trédan, Damien Pouessel, Nicolas Penel

|Mar 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.

Allison Voisin, Catherine Terret, Camille Schiffler

|May 23, 2023
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort.

Alison Antoine, David Pérol, Mathieu Robain

|Feb 04, 2020
Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study.

Lidia Delrieu, Vincent Pialoux, Olivia Pérol

|Nov 28, 2018
A 96-hour continuous wound infiltration with ropivacaine reduces analgesic consumption after liver resection: A randomized, double-blind, controlled trial.

Véronique Peres-Bachelot, Ellen Blanc, Nadia Oussaid

Pageof 2

Frequent Collaborators

4 joint publications

Olivier Trédan

2 joint publications

Lidia Delrieu

2 joint publications

Olivia Pérol

2 joint publications

Béatrice Fervers

2 joint publications

Christine Friedenreich

2 joint publications

Jean-Yves Blay

2 joint publications

Olivia Febvey-Combes

2 joint publications

Eva Roitmann

2 joint publications

Armelle Dufresne

2 joint publications

Thomas Bachelot

Frequent Collaborators

4 joint publications

Olivier Trédan

2 joint publications

Lidia Delrieu

2 joint publications

Olivia Pérol

2 joint publications

Béatrice Fervers

Top Related Videos

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

Published on : Feb 19, 2021

1.6K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

24.3K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.9K
See more related videos

Top Related Videos

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

Published on : Feb 19, 2021

1.6K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

24.3K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.9K
See more related videos